Skip to search.
 TSX Up 0.65% TSX Ventures Down 0.16%

AstraZeneca PLC (AZN)

-NYSE
69.94 Down 0.13(0.19%) 4:05PM EDT
|After Hours : 69.98 Up 0.04 (0.06%) 5:17PM EDT
Add to Portfolio
Prev Close:70.07
Open:69.47
Bid:69.10 x 200
Ask:73.35 x 100
1y Target Est:75.73
Beta:0.86
Next Earnings Date:N/A
Day's Range:69.45 - 70.16
52wk Range:61.80 - 82.68
Volume:842,185
Avg Vol (3m):1,644,180
Market Cap:88.34B
P/E (ttm):71.59
EPS (ttm):0.98
Div & Yield:3.80 (5.40%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AZNDown 0.19%88.34B
GSKUp 0.38%113.54B
MRKUp 1.02%165.58B
PFEUp 1.36%214.51B

Key Statistics

Forward P/E (1 yr):17.31
P/S (ttm):3.39
Ex-Dividend Date:18-Feb-15

Analysts

Annual EPS Est (Dec-15) :4.24
Quarterly EPS Est (Mar-15) :1.15
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-167.20

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback